Valuations14 Apr 2026 16:15
So just to be clear: a company bought for £1 billion, with a process targeting AML, has basically failed.
HEMO, with a process which has not failed and is very likely to succeed, is valued at --?
Not 1 billion. Not even 100 million. About 60 million at today's prices.
The only logical response is to buy more shares, if you have the cash.